Clinical Trial Update: Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating treatment of unacceptable bleeding patterns in ETG implant users using an oral contraceptive; the study was terminated and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding
• Heavy Menstrual Bleeding

Drugs mentioned

• Oral contraceptive

Snippet

Sponsor: University of California, Davis | Conditions: Abnormal Uterine Bleeding, Unspecified, Uterine Bleeding Heavy | Phase 4 | Status: TERMINATED | Results posted: 2017-05-12